Conference
Longitudinal Changes in Relative Market Share Proportions of Biologic, and Targeted Synthetic, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) for Treatment of Rheumatoid Arthritis: Results from the Ontario Best Practices Research Initiative (OBRI)
Authors
Hepworth E; Movahedi M; Rampakakis E; Mirza R; Lau A; Cesta A; Pope J; Sampalis J; Bombardier C
Volume
46
Pagination
pp. 821-821
Publisher
J RHEUMATOL PUBL CO
Publication Date
July 1, 2019
Name of conference
Meeting of the Canadian-Rheumatology-Association
Conference place
CANADA, Montreal
Conference start date
February 27, 2019
Conference end date
March 2, 2019
Conference proceedings
JOURNAL OF RHEUMATOLOGY
Issue
7
ISSN
0315-162X